0070081
print

Growth Hormone, 0 Minutes

GH 0
Example Reports
Abnormal
Normal

Ordering Recommendation

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Plasma separator tube or serum separator tube. Collect one tube per timed specimen. Also acceptable: Green (sodium or lithium heparin) or lavender (EDTA), or pink (K2EDTA).

Specimen Preparation

Allow specimen to clot completely at room temperature.  Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma per timed specimen to individual ARUP Standard Transport Tubes. (Min: 0.4 mL per timed specimen)

Storage/Transport Temperature

Frozen. Also acceptable: Refrigerated.

Unacceptable Conditions

Tissue or urine. Grossly hemolyzed or lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 2 months

Methodology

Quantitative Chemiluminescent Immunoassay

Performed

Sun-Sat

Reported

1-2 days

Reference Interval

Effective May 20, 2013

Age
 Male
 Female
0-6 years 0.10-6.20 ng/mL 0.10-6.20 ng/mL
7-17 years 0.05-11.00 ng/mL 0.05-17.30 ng/mL
18 years and older 0.05-3.00 ng/mL 0.05-8.00 ng/mL

Interpretive Data

For pediatric patients, very low peak growth hormone (GH) concentrations on stimulation testing are consistent with severe GH deficiency (GHD). Thresholds distinguishing normal from partial GHD have not been well established. Inadequate response to two different provocative tests is required for diagnosis of GHD. (Grimberg et al. Horm Res Paediatr 2016;86:361-397).
 
In adults, expected peak GH concentrations depend on the stimulation test performed, as described in Endocrine Society guidelines for the evaluation and treatment of adults with GHD (Yuen KCJ et al. Endocr Pract. 2019;25(11):1191-1232).
 
For suppression testing, healthy subjects have GH concentrations of less than 1 ng/mL within 2 hours of ingestion of a 75 or 100 gram glucose dose. Patients with acromegaly fail to show normal suppression. (Katznelson et al. J Clin Endocrinol Metab, 2014, 99(11):3933-3951).

Compliance Category

FDA

Note

This Growth Hormone assay is now standardized to the Recombinant Second International Standard (IS): 98/574. Growth hormone results read approximately 25 percent lower than with the previous standards (First IS: 80/505). Reference ranges have also been modified according to the assay manufacturer.

Hotline History

N/A

CPT Codes

83003

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0070081 Growth Hormone 0 Minutes 12253-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • GH
  • GH testing
  • GHRH
  • Growth Hormone Provocative Test
  • Growth Hormone Stimulation
  • growth hormone, Serum
  • hGH
  • Human Growth Hormone
  • Somatotrophic Hormone
  • Somatotropin
Growth Hormone, 0 Minutes